Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb (NYSE:BLCO) with a Outperform and raises the price target...
Goldman Sachs analyst David Roman initiates coverage on Bausch & Lomb (NYSE:BLCO) with a Neutral rating and announces Pr...
enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter studyResu...
XIIDRA significantly improved end-of-day eye dryness and discomfort and delivered longer comfortable contact lens wear time in ...
ASANA offers a comprehensive, customizable gas permeable portfolio including spherical, aspheric, toric, multifocal, reverse ge...
Morgan Stanley analyst Patrick Wood maintains Bausch & Lomb (NYSE:BLCO) with a Equal-Weight and raises the price target ...
HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb (NYSE:BLCO) with a Buy and raises the price target from ...
Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb (NYSE:BLCO) with a Equal-Weight and raises the price target ...
Bausch & Lomb (NYSE:BLCO) raises FY2025 sales outlook from $5.000 billion-$5.100 billion to $5.050 billion-$5.150 billion v...
